Corporate
Minerva Neurosciences Details Phase 3 Roluperidone Trial at LifeSci KOL Event — First Patient Expected Q2 2026
Feb 3
You're signed outSign in or to get full access.
Minerva Neurosciences Inc (NERV) Earnings Call Transcripts
Browse quarterly earnings call transcripts for Minerva Neurosciences Inc.
No earnings call transcripts available for NERV.